Beschreibung
Change from baseline in IBS symptom severity scores (IBS-SSS) across treatment groups, indicating that both probiotic strains were associated with greater symptom relief compared to placebo.
Figure 3
ChartSource Paper
Lactobacillus acidophilus DDS-1 and Bifidobacterium lactis UABla-12 Improve Abdominal Pain Severity and Symptomology in Irritable Bowel Syndrome: Randomized Controlled Trial.Cite This Figure
![Figure 3: Change from baseline in IBS symptom severity scores (IBS-SSS) across treatment groups, indicating that both probiotic strains were associated with greater symptom relief compared to placebo.]() > Source: Christopher J Martoni et al. "Lactobacillus acidophilus DDS-1 and Bifidobacterium lactis UABla-12 Improve Abdo." *Nutrients*, 2020. PMID: [32019158](https://pubmed.ncbi.nlm.nih.gov/32019158/)
<figure> <img src="" alt="Change from baseline in IBS symptom severity scores (IBS-SSS) across treatment groups, indicating that both probiotic strains were associated with greater symptom relief compared to placebo." /> <figcaption>Figure 3. Change from baseline in IBS symptom severity scores (IBS-SSS) across treatment groups, indicating that both probiotic strains were associated with greater symptom relief compared to placebo.<br> Source: Christopher J Martoni et al. "Lactobacillus acidophilus DDS-1 and Bifidobacterium lactis UABla-12 Improve Abdo." <em>Nutrients</em>, 2020. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/32019158/">32019158</a></figcaption> </figure>